Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by

Cancer biologists are yet to understand the mechanisms and cellular hierarchy leading to the developmental arrest in rhabdomyosarcoma (RMS)—a group of pediatric cancers, which remain enigmatic.

Leave A Comment

Your email address will not be published. Required fields are marked *